As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CVS Health: Portman Square Capital LLP, IMC Chicago LLC, Nomura Holdings Inc., Readystate Asset Management LP, GTS Securities LLC, Barclays PLC, Wolverine Trading LLC, Paloma Partners Management Co, Parallax Volatility Advisers L.P., HAP Trading LLC, Caas Capital Management LP, Citadel Advisors LLC, Point72 Asset Management L.P., Cubist Systematic Strategies LLC, Balyasny Asset Management L.P., Nomura Holdings Inc., Verition Fund Management LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Eisler Capital US LLC, Eisler Capital UK Ltd., Goldman Sachs Group Inc., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Mendel Money Management, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Portman Square Capital LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.